RxDoctor Payments Data

Joshua Cabrera, MD

Psychiatry · Bryan, TXNPI 1235254483

Payments from drug & device makers

$1,750in general payments, 2019–2025

Across 94 payments — averaging $18.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$304
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$250
  • AbbVie$197
  • Johnson & Johnson$173
  • Sunovion Pharmaceuticals Inc.$146
  • Otsuka America Pharmaceutical, Inc.$139
  • plus $542 from 9 others

What the payments were for

  • Food & beverage$1,72398%
  • Education$272%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,750 in reported general payments places this provider in the 75th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas

Medicare billing

Part B allowed, 2024
$3,234
Medicare patients
33
Services billed
127

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate60$155,719
Aripiprazole63$3,437
Quetiapine Fumarate78$1,693
Hydroxyzine Hcl57$1,177
Buspirone Hcl75$1,113
Lurasidone Hcl27$1,096
Fluphenazine Decanoate11$1,092
Benztropine Mesylate99$1,077
Haloperidol Decanoate26$971
Olanzapine52$857
Mirtazapine56$847
Prazosin Hcl44$726
Oxcarbazepine15$631
Perphenazine12$589
Hydroxyzine Pamoate48$577

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$173$155,71960 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,238 psychiatry providers in Texas.

Other psychiatry in Bryan

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →